Replies to post #78332 on Cytodyn Inc (CYDY)

[Amatuer17]

I can think of AVXL as one that moved from OTC to Nasdaq - but not a big success - just so so performance after 3-4 years of uplisting (they did r/s to get up listed so the share count is reasonable)

They are one trial result away from making it big or biting dust - the result will come by end of June

[tcbush]

Not a winner yet but going up
APDN

[BioInvestor4]

Off the top of my head, Monster Energy Drinks (MNST) was one of the biggest. Used to trade at 4 cents. Now is $66

[SmileyRiley_595]

An oldie but a goodie... Mylan

On February 23, 1973, Mylan had its initial public offering (IPO),[34] becoming a publicly traded company on the OTC market under the ticker symbol MYLN. In 1976 the stock moved to NASDAQ. Their final stock move was in 1986, when their stock became available for trade on the New York Stock Exchange under the ticker symbol MYL. Currently, the stock is traded on the NASDAQ.

[tonysd57]

Yes, I was invested in Cytosorbents ( Novel Blood Filter to Reduce Cytokine Storm) CTSO from 2012-2015. They traded between .08cts-30cts for years and as they're we're nearing EU approval, primarily in German hospitals, they effected a 25 to 1 spilt- My 450,000 shares at .12cts became 18,000 at $3.00.

I & most investors very much welcomed the move as they were loaded down with 650 million shares that suddenly became a very tight 26,000,000 - they crossed over on Dec. 1st 2014 at .21cts or $5.25 and held there for thirty days then gradually over the next 60 days ran to $13.00

So my one/only experience with R/S was very favorable- They've bounced around in past five years from $3.00 to $15.00 -- Cytodyn has a universe of possibilities compared to CTSO, that's why it's my repeated hope they will find the way/huevos to crossover at $4.00 minimum, or $5.00 preferred to give every institutional investor, hedge fund, etc the opportunity to push us much much higher--